Scinai Immunotherapeutics LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Mark Germain, a Director at Scinai Immunotherapeutics Ltd., acquired 120,000,000 ordinary shares through a grant of restricted share units.
NASDAQ
SCNI CEO Amir Reichman has acquired 400,000,000 ordinary shares through restricted share units (RSUs) granted on June 16, 2026.